Live feed
Filing
SC 13G
SC 13G0001062993-22-003816·Advent Life Sciences LLP
Schedule 13G ownership disclosure
Aura Biosciences Inc
Security class unavailable · CUSIP: 05153U107
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,023,857
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-22-003816
- Form type
- SC 13G
- Filer
- Advent Life Sciences LLP
- CIK
- CIK 1601364
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership